Surepost tablets 0.25mg, manufactured by Sumitomo Pharma, contain Repaglinide, a meglitinide-class antidiabetic drug used for blood sugar control in type 2 diabetes. It is a 0.25 mg 1 tablet with YJ code 3969013F1020, and acts by stimulating insulin release.
Surepost tablets 0.25mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
